Nazione: Regno Unito
Lingua: inglese
Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)
Amitriptyline hydrochloride
Rosemont Pharmaceuticals Ltd
N06AA09
Amitriptyline hydrochloride
10mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030100; GTIN: 5016119070891
0 10 20 30 40 50 60 70 80 90 100 JOB INFORMATION Product Name: Strength: Keyline Ref: Font Type: Font Size: Pharmacode: Dimensions: EAN Code: Folded Size: No. of Colours: Tabbed: Pack Size: Bottle Size: Design Icon: Print Colours: Non-print Colours: New Item Code: Previous Item Code: Supplier Code: Page Number: COLOURS ARTWORK VERSION: Date: Date: Operator: Operator: PREFLIGHT VERSION: JOB SPECIFICATION MAIN BODY TEXT Univers Roman UNIVERS BOLD 50mg/5ml BLACK 7474 PANTONE PANTONE 265 KEYLINE BRAILLE UKL413 408 150 x 500mm N/A 150 x 33mm 1 8pt (horizontally condensed to 90%) No 150ml 150ml N/A F5ND1RBJ2 F5ND1RBJ1 N/A 1 of 2 Amitriptyline Hydrochloride 50mg/5ml Oral Solution 20/04/18 - DH - 3 - APPROVALS THIRD PARTY APPROVAL REQUIRED Name: Name: Signature: Signature: Date: Date: AUTHORITY APPROVAL SUPPLIED REGULATORY SIGN-OFF YES YES NO N/A TICK APPLICABLE BOX TICK APPLICABLE BOX READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. n Keep this leaflet. You may need to read it again. n If you have any further questions, ask your doctor or pharmacist. n This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. n If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Amitriptyline 50mg/5ml Oral Solution is and what it is used for 2. What you need to know before you take Amitriptyline 50mg/5ml Oral Solution 3. How to take Amitriptyline 50mg/5ml Oral Solution 4. Possible side effects 5. How to store Amitriptyline 50mg/5ml Oral Solution 6. Contents of the pack and other information 1. WHAT AMITRIPTYLINE 50MG/5ML ORAL SOLUTION IS AND WHAT IT IS USED FOR Amitriptyline belongs to a group of medicines known as tricyclic antidepressants. This medicine is used to treat: n Depression in adults (major depressive episodes) n Neuropathic pain in adul Leggi il documento completo
OBJECT 1 AMITRIPTYLINE HYDROCHLORIDE 50MG/5ML ORAL SOLUTION Summary of Product Characteristics Updated 03-May-2018 | Rosemont Pharmaceuticals Limited 1. Name of the medicinal product Amitriptyline Hydrochloride 50mg/5ml Oral Solution 2. Qualitative and quantitative composition Amitriptyline Hydrochloride 50mg/5ml 3. Pharmaceutical form Oral Solution 4. Clinical particulars 4.1 Therapeutic indications Amitriptyline is indicated for: • the treatment of major depressive disorder in adults • the treatment of neuropathic pain in adults • the prophylactic treatment of chronic tension type headache (CTTH) in adults • the prophylactic treatment of migraine in adults • the treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This medicinal product should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis. 4.2 Posology and method of administration Posology Not all dosage schemes can be achieved with all the pharmaceutical forms/strengths. The appropriate formulation/strength should be selected for the starting doses and any subsequent dose increments. _Major depressive disorder _ Dosage should be initiated at a low level and increased gradually, noting carefully the clinical response and any evidence of intolerability. _Adults_ Initially 25 mg 2 times daily (50 mg daily). If necessary, the dose can be increased by 25 mg every other day up to 150 mg daily divided into two doses. The maintenance dose is the lowest effective dose. _Elderly patients over 65 years of age and patients with cardiovascular disease _ Initially 10 mg – 25 mg daily. The daily dose may be increased up to 100 mg – 150 mg divided into two doses, depending on individual patient response and tolerability. Doses above 100 mg should be used with caution. Th Leggi il documento completo